Title |
Author |
Type |
Date |
Words |
PharmaCyte Biotech Initiates Studies to Confirm Its Pancreatic Cancer Therapy Can Treat Malignant Ascites. |
|
|
May 23, 2022 |
722 |
Thermo Fisher Scientific, LabShares Partner to Support Emerging Boston Biotechs. |
|
|
May 20, 2022 |
193 |
Trinity Biotech announces CE Mark for 10-minute COVID-19 antigen test. |
|
|
May 20, 2022 |
171 |
Adverum Biotechnologies presents research piepline data at ASGCT. |
|
|
May 19, 2022 |
314 |
Brickell Biotech doses first subject in Phase 1 study of BBI-01. |
|
|
May 19, 2022 |
205 |
PolyU's Pioneering Technologies in AI, Materials Science and Biotechnology Awarded at TechConnect 2022 Innovation Awards. |
|
|
May 19, 2022 |
622 |
Thermo Fisher Scientific Partners with LabShares to Support Emerging Boston Biotechs. |
|
|
May 19, 2022 |
169 |
Thermo Fisher Scientific Partners with LabShares to Support Emerging Boston Biotechs. |
|
|
May 19, 2022 |
182 |
IO Biotech announces initiation of Phase 3 trial of IOB102-IOB103, KEYTRUDA. |
|
|
May 18, 2022 |
215 |
Precision BioSciences publishes data from in vivo gene editing program. |
|
|
May 18, 2022 |
292 |
Purple Biotech announces initiation of Phase 2 study for CM24. |
|
|
May 18, 2022 |
228 |
'Pak-Turk-Kazakh Youth Forum on Biotech' to be held in Sept. |
|
|
May 16, 2022 |
470 |
Gulf Biotech to manufacture injectable drugs. |
|
|
May 12, 2022 |
290 |
Brickell Biotech reports Q1 EPS (8c), consensus (6c). |
|
Financial report |
May 12, 2022 |
217 |
'Pak-Turk-Kazakh Youth Forum on Biotech' to be held in September. |
|
|
May 11, 2022 |
470 |
PDS Biotechnology reports Q1 EPS (32c), consensus (22c). |
|
Financial report |
May 11, 2022 |
180 |
Evaxion Biotech reports Q1 EPS (25c), consensus (33c). |
|
Financial report |
May 11, 2022 |
174 |
Iroquois: PharmaCyte Biotech has failed to create meaningful value for holders. |
|
|
May 11, 2022 |
289 |
Moleculin Biotech receives approval from UK MHRA for Phase 1a study of WP1122. |
|
|
May 10, 2022 |
195 |
SQZ Biotechnologies to Make First Data Presentation on Non-Clinical Studies of Point-of-Care Manufacturing System and Collaboration with Stemcell Technologies on Research-Use-Only System to Fuel Preclinical Research. |
|
Clinical report |
May 10, 2022 |
507 |
Unity Biotechnology reports Q1 EPS (28c), consensus (26c). |
|
Financial report |
May 10, 2022 |
173 |
Moleculin Biotech's Phase 1/2 Annamycin study in AML allowed to proceed. |
|
|
May 5, 2022 |
163 |
Unity Biotechnology presents on UBX1325 at ARVO 2022. |
|
|
May 5, 2022 |
322 |
Vir Biotechnology reports Q1 EPS $3.85, consensus $3.78. |
|
Financial report |
May 5, 2022 |
222 |
Agastiya Biotech and Vopec Pharmaceuticals' AB001 granted US FDA Orphan Drug Designation. |
|
|
May 4, 2022 |
196 |
Agastiya Biotech and Vopec Pharmaceuticals' AB001 granted US FDA Orphan Drug Designation. |
|
|
May 4, 2022 |
197 |
SIU's $13M interdisciplinary fermentation, food and biotech research hub advances. |
TIM CROSBY SIU News Service |
|
May 4, 2022 |
1141 |
Virica Biotech Forges Collaboration with the Government of Canada. |
|
|
May 3, 2022 |
273 |
Orgenesis announces MIDA Biotech received approval for EUR4M grant. |
|
|
May 3, 2022 |
211 |
Plant-Based Bimetallic Silver-Zinc Oxide Nanoparticles: A Comprehensive Perspective of Synthesis, Biomedical Applications, and Future Trends. |
Ehsan, Maria; Waheed, Abdul; Ullah, Abd; Kazmi, Abeer; Ali, Amir; Raja, Naveed Iqbal; Mashwani, Zia- |
Report |
Apr 30, 2022 |
14424 |
Altered molecular pathways and prognostic markers in active systemic juvenile idiopathic arthritis: Integrated bioinformatic analysis. |
Ren, Yi; Labinsky, Hannah; Palmowski, Andriko; Backer, Henrik; Muller, Michael; Kienzle, Arne |
Report |
Apr 30, 2022 |
7377 |
Vir Biotechnology announces new data from MARCH hepatitis B trial. |
|
|
Apr 27, 2022 |
412 |
MAIA biotechnology Receives FDA Orphan Drug Designation for THIO for the Treatment of Hepatocellular Carcinoma. |
|
|
Apr 26, 2022 |
289 |
ILiAD Biotechnologies Receives NIH Grant to Develop Novel Tuberculosis Vaccine Using Proprietary B-Tech Vector Platform. |
|
|
Apr 26, 2022 |
809 |
£2.5m to help Newcastle biotech firm launch world-first skin cancer test in the UK and USA; Newcastle Uni spin-out company AMLo Biosciences has received almost £2.5m to help it launch a new skin cancer test which could help reduce the mammoth pressure on the NHS. |
By, Sam Volpe |
|
Apr 26, 2022 |
696 |
Human genome sequence recorded in Bahrain. |
|
|
Apr 25, 2022 |
478 |
First complete sequence of human genome sequence recorded in Bahrain. |
|
|
Apr 24, 2022 |
463 |
Biotechnology Remains Nigeria's Engine-room for Food Security, Zero Hunger'. |
|
|
Apr 22, 2022 |
386 |
Moleculin Biotech receives IND clearance for Phase 1 study of glioma candidate. |
|
|
Apr 21, 2022 |
186 |
Legend Biotech Achieves Milestone Under Collaboration Agreement with Janssen Biotech, Inc. for BCMA CAR-T. |
|
|
Apr 21, 2022 |
370 |
Fighting hunger with biotech food. |
|
|
Apr 21, 2022 |
909 |
Unity Biotechnology doses first patient in ENVISION study of UBX1325. |
|
|
Apr 19, 2022 |
180 |
PharmaCyte Biotech announces results from pancreatic cancer clinical trial. |
|
|
Apr 19, 2022 |
228 |
Gulf Biotech to manufacture injectable drugs in Bahrain. |
|
|
Apr 17, 2022 |
315 |
NHRA licenses Gulf Biotech to manufacture injectable drugs. |
|
|
Apr 16, 2022 |
297 |
Evelo Biosciences updates guidance on clinical inflammation programs. |
|
|
Apr 14, 2022 |
200 |
Moleculin Biotech announces corporate rebranding, launch of new website. |
|
Website overview |
Apr 14, 2022 |
159 |
SQZ Biotechnologies Presents New eAPC Preclinical Data Demonstrating That Multiplexed mRNA Engineering of Immune Cells Increases Killer T Cell Activity In Vivo. |
|
|
Apr 14, 2022 |
698 |
Purigen Biosystems Expands Commercial Presence in European Union with GC biotech Distribution Agreement. |
|
|
Apr 14, 2022 |
272 |
Nigeria, Cuba To Deepen Ties On Biotechnology Development. |
|
|
Apr 14, 2022 |
218 |
Qatar, Sinovac Biotech donate 75K Covid-19 jabs to PH. |
|
|
Apr 13, 2022 |
297 |
Portage Biotech highlights data presented on PORT-5 at AACR 2022. |
|
|
Apr 13, 2022 |
207 |
Daewoong Pharmaceutical and HanAll Biopharma expand open collaboration strategy by investing in Turn Biotechnologies. |
|
|
Apr 12, 2022 |
188 |
Daewoong Pharmaceutical and HanAll Biopharma expand open collaboration strategy by investing in Turn Biotechnologies. |
|
|
Apr 12, 2022 |
187 |
Unity Biotechnology completes enrollment in BEHOLD study. |
|
|
Apr 12, 2022 |
172 |
Ansa Biotechnologies Closes Oversubscribed USD 68m Series A Financing to Power the Next Era of DNA-Enabled Industries. |
|
|
Apr 12, 2022 |
558 |
Purple Biotech presents interim Phase 1b study results for CM24. |
|
|
Apr 11, 2022 |
318 |
Trinity Biotech enters $45M strategic investment, partnership with MiCo. |
|
|
Apr 11, 2022 |
680 |
Biotech breakthrough in virus vaccines. |
|
|
Apr 11, 2022 |
253 |
Nigeria, Cuba To Deepen Ties On Biotechnology Development. |
|
|
Apr 11, 2022 |
220 |
PDS Biotechnology reports inducement grants under Nasdaq listing rule. |
|
|
Apr 8, 2022 |
169 |
Moleculin Biotech to present preclinical annamycin data at AACR. |
|
|
Apr 8, 2022 |
248 |
IO Biotech presents new data from MM1636 Phase 1/2 trial. |
|
|
Apr 8, 2022 |
270 |
VM biotechnology Awarded USD 1.6m Phase II SBIR Grant to Study AVM0703's Potential to Reverse Type 1 Diabetes. |
|
|
Apr 6, 2022 |
627 |
Ghanaian Delegation To Understudy Nigeria's Regulatory Infrastructure, Policies In Biotechnology. |
|
|
Apr 6, 2022 |
614 |
Ghanaian Delegation To Understudy Nigeria's Regulatory Infrastructure, Policies In Biotechnology. |
|
|
Apr 5, 2022 |
610 |
Ghana Applauds Nigeria's Biotechnology Success Story. |
|
|
Apr 5, 2022 |
478 |
Roche, world's biggest biotech company, officially opens new site in Cape Town. |
|
|
Apr 5, 2022 |
390 |
WHO suspends supply of Bharat Biotech's COVID-19 through UN agencies. |
|
|
Apr 4, 2022 |
226 |
WHO suspends supply of Bharat Biotech's COVID-19 through UN agencies. |
|
|
Apr 4, 2022 |
227 |
Dye Ligand Affinity Nanoparticles for the Depletion of Biomolecules in Proteomics. |
Kusat, Kevser |
|
Apr 1, 2022 |
3405 |
Portage Biotech provides update on clinical-stage, development programs. |
|
|
Mar 31, 2022 |
430 |
United Airlines, Oxy Low Carbon Ventures Work with Biotech Firm to Create New Fuel Sources. |
|
|
Mar 30, 2022 |
337 |
United Airlines, Oxy Low Carbon Ventures Work with Biotech Firm to Create New Fuel Sources. |
|
|
Mar 30, 2022 |
320 |
Shanghai Henlius Biotech's HANSIZHUANG receives Chinese regulatory approval. |
|
|
Mar 28, 2022 |
238 |
Shanghai Henlius Biotech's HANSIZHUANG receives Chinese regulatory approval. |
|
|
Mar 28, 2022 |
237 |
Fortress Biotech reports 2021 EPS 25c, consensus (26c). |
|
Financial report |
Mar 28, 2022 |
426 |
Krystal Biotech announces publication of Phase 1, 2 trial data of B-VEC. |
|
|
Mar 28, 2022 |
264 |
Vir Biotechnology, GlaxoSmithKline: FDA amends EUA Fact Sheet for sotrovimab. |
|
|
Mar 25, 2022 |
156 |
Vir Biotechnology gives additional information on sotrovimab EUA amendment. |
|
|
Mar 25, 2022 |
228 |
Evaxion Biotech reports Q4 EPS (39c), consensus (29c). |
|
Financial report |
Mar 22, 2022 |
187 |
Edesa Biotech announces $10M registered direct offering. |
|
|
Mar 22, 2022 |
179 |
Lixte Biotechnology announces new findings on OCCC patients. |
|
|
Mar 22, 2022 |
190 |
PharmaCyte Biotech completes 24-month CypCaps product stability study. |
|
|
Mar 22, 2022 |
226 |
Viva Biotech adds to production of oral COVID-19 drug molnupiravir in the joint fight against COVID-19. |
|
|
Mar 21, 2022 |
249 |
Viva Biotech adds to production of oral COVID-19 drug molnupiravir in the joint fight against COVID-19. |
|
|
Mar 21, 2022 |
248 |
SQZ Biotechnologies Announces USD 2m Grant from the National Institutes of Health to Develop a Novel, Scalable Cell Replacement Therapy for Parkinson's Disease. |
|
|
Mar 21, 2022 |
331 |
Founders of Taiwan biotech firm sentenced for stealing trade secrets from Genentech. |
|
|
Mar 17, 2022 |
326 |
Protagonist Therapeutics earns $25M milestone payment from Janssen Biotech. |
|
|
Mar 16, 2022 |
157 |
Sana Biotechnology reports Q4 EPS (65c) vs ($2.98) last year. |
|
Financial report |
Mar 16, 2022 |
164 |
MAIA biotechnology Raises USD 2.4m in Equity Financing. |
|
|
Mar 16, 2022 |
384 |
SQZ Biotechnologies reports FY21 EPS ($2.49), consensus ($2.75). |
|
Financial report |
Mar 16, 2022 |
166 |
PHL files updated biotechnology rules covering beneficial GMOs. |
|
|
Mar 15, 2022 |
532 |
Krystal Biotech enters binding term sheet for settlement with PeriphaGen. |
|
|
Mar 15, 2022 |
196 |
Brickell Biotech reports Q4 EPS (6c), consensus (8c). |
|
Financial report |
Mar 15, 2022 |
164 |
PDS Biotechnology says NCi achieves enrollment objective in Phase 2 trial. |
|
|
Mar 15, 2022 |
209 |
Applied DNA Executes LOI with Spindle Biotech for Research Collaboration on Simplified High Yield mRNA Production System. |
|
|
Mar 14, 2022 |
551 |
US Biotech InSitu Biologics Joins the in5 Incubator in UAE. |
|
|
Mar 11, 2022 |
207 |
Vladimir Putin's secret stash of chemical weapons -including anthrax and Ebola; The massive centre, known as Vector, in Siberia is believed to house deadly diseases such as small pox and anthrax in the Research on Virology and Biotechnology. |
By, Chris Hughes & Antony Thrower |
|
Mar 11, 2022 |
526 |
Substantial training course on recent trends in biotechnology gets underway at SU. |
|
|
Mar 8, 2022 |
818 |
Substantial Training Course On Recent Trends In Biotechnology Gets Underway At SU. |
|
|
Mar 8, 2022 |
399 |
Substantial training course on recent trends in biotechnology gets underway at SU. |
|
|
Mar 8, 2022 |
818 |
NUMS' scientist makes breakthrough by developing much cheaper source of Omega-3, through biotechnology. |
|
|
Mar 7, 2022 |
393 |
NUMS' scientist makes breakthrough by developing much cheaper source of Omega-3 using biotechnology. |
|
|
Mar 6, 2022 |
392 |
ARISTA Biotech Plans Hong Kong Cleanroom Production Plant for COVID-19 Rapid Test Kits; Donates 15,00. |
|
|
Feb 17, 2022 |
417 |
US FDA Places Clinical Hold of Legend Biotech Phase 1 Clinical Trial for LB1901. |
|
|
Feb 15, 2022 |
239 |
Pluslife Biotech unveils first handheld Covid-19 Nucleic Acid Test in Hong Kong. |
|
|
Feb 14, 2022 |
251 |
Pluslife Biotech unveils first handheld Covid-19 Nucleic Acid Test in Hong Kong. |
|
|
Feb 14, 2022 |
252 |
Legend Biotech Achieves Milestone Payments in BCMA CAR-T Collaboration with Janssen. |
|
|
Feb 14, 2022 |
378 |
EdiGene, Arbor Biotechnologies Ink License for CRISPR Technology. |
|
|
Feb 9, 2022 |
286 |
SAN Group to set up new green biotechnology facility in Rakez. |
Jason Saundalkar |
|
Feb 9, 2022 |
399 |
SAN Group to set up new green biotechnology facility in Rakez. |
Jason Saundalkar |
|
Feb 9, 2022 |
420 |
Active Biotech agrees licence for tasquinimod in MF. |
|
|
Feb 9, 2022 |
188 |
Active Biotech agrees licence for tasquinimod in MF. |
|
|
Feb 9, 2022 |
186 |
Active Biotech agrees licence for tasquinimod in MF. |
|
|
Feb 9, 2022 |
187 |
Austrian group to build green biotechnology facility in RAK. |
|
|
Feb 8, 2022 |
417 |
Algae the key as KAUST seaweed biotech aims to boost Kingdom's fisheries. |
George Charles Darley |
|
Feb 8, 2022 |
641 |
SAN Group to set up $3m green biotechnology unit in Ras Al Khaimah. |
|
|
Feb 8, 2022 |
403 |
Active Biotech reports first patient dosed in combination part of multiple myeloma study. |
|
Clinical report |
Feb 7, 2022 |
164 |
Active Biotech reports first patient dosed in combination part of multiple myeloma study. |
|
Clinical report |
Feb 7, 2022 |
165 |
Active Biotech reports first patient dosed in combination part of multiple myeloma study. |
|
Clinical report |
Feb 7, 2022 |
163 |
S. African biotech firm makes Africa's first mRNA vaccine. |
|
|
Feb 4, 2022 |
576 |
Acticor Biotech announces encouraging results from Phase 2 GARDEN study in COVID-19 ARDS. |
|
Clinical report |
Feb 3, 2022 |
257 |
Acticor Biotech announces encouraging results from Phase 2 GARDEN study in COVID-19 ARDS. |
|
Clinical report |
Feb 3, 2022 |
258 |
Minerva Biotechnologies Opens 1st-In-Human Phase I/II Trial of a MUC1*Targeting CAR T for Metastatic Breast Cancers at city of Hope. |
|
|
Feb 2, 2022 |
214 |
Abcam Collaborates with Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications. |
|
|
Feb 1, 2022 |
455 |
US Food and Drug Administration grants Nanjing Bioheng Biotech's CTB001 Orphan Drug Designation. |
|
|
Jan 31, 2022 |
163 |
US Food and Drug Administration grants Nanjing Bioheng Biotech's CTB001 Orphan Drug Designation. |
|
|
Jan 31, 2022 |
162 |
Covaxin now a universal COVID vaccine for adults, children: Bharat Biotech. |
|
|
Jan 29, 2022 |
311 |
Cellino Biotech Closes USD 80m Series A Financing Led by Bayer. |
|
|
Jan 26, 2022 |
286 |
SQZ Biotechnologies Receives FDA Clearance of Investigational New Drug Application for SQZ-eAPC-HPV, a Novel mRNA-based Cell Therapy for the Treatment of HPV16 Positive Solid Tumors. |
|
|
Jan 24, 2022 |
716 |
Virica Biotech Forges R and D Partnership with Oxford Biomedica to Improve the Manufacturing of Lentiviral Vector Gene Therapies Using Viral Sensitizers. |
|
|
Jan 24, 2022 |
352 |
'Wonder pill' breakthrough containing combined Covid and flu vaccines; Brit biotech firm iosBio has made a breakthrough in the making of a combined flu and Covid vaccine pill that would be a massive boost in tackling the respiratory viruses. |
By, Tim Hanlon |
|
Jan 22, 2022 |
519 |
Parse Biosciences Forges Partnership with Research Instruments Group to Offer RNA-Seq Kits in Singapore and Southeast Asia Region. |
|
|
Jan 20, 2022 |
371 |
Novak Djokovic owns 80% stake in biotech firm aiming to develop Covid treatment; Novak Djokovic has been strong in his stance against the Covid vaccine, and now it has emerged that he holds a majority stake at a Danish biotech firm aiming to develop a treatment against the virus. |
By, Liam Llewellyn |
|
Jan 19, 2022 |
335 |
Nashville Biosciences, Illumina Ink Agreement to Establish Preeminent Clinico-Genomic Resource for Life Sciences Research and Development. |
|
|
Jan 14, 2022 |
522 |
Bharat Biotech's Covaxin COVID-19 booster shot neutralises Omicron variant. |
|
|
Jan 12, 2022 |
154 |
Bharat Biotech's Covaxin COVID-19 booster shot neutralises Omicron variant. |
|
|
Jan 12, 2022 |
155 |
Massive PS730m cancer drug deal for biotech firm. |
COREENA FORD Business Reporter coreena.ford@reachplc.com @scoopford |
|
Jan 11, 2022 |
399 |
Stronger policy on agri-biotech pushed for progressive, resilient food system. |
|
|
Jan 9, 2022 |
579 |
FDA Grants ILiAD Biotechnologies Fast Track Designation for Next Generation Pertussis Vaccine BPZE1. |
|
|
Jan 3, 2022 |
679 |
The Role of Policy in Supporting a Globally Diverse Bio-Economy That Mitigates Climate Change and Food Insecurity. |
Zilberman, David; Wesseler, Justus |
|
Jan 1, 2022 |
2048 |
Turkey set to build vaccine, biotech hub in capital Ankara. |
|
|
Dec 31, 2021 |
405 |
Cyrus Biotechnology's COVID Therapeutic Lead, ACE2.v2.4, Strongly Binds and Neutralizes SARS-CoV-2 Omicron Variant Potentially Providing Long Term Protection. |
|
|
Dec 30, 2021 |
416 |
Biotech firm moves into city science park; helping to develop new vaccines. |
DANIEL CLARK Daniel.Clark@reachplc.com @HEDANIELCLARK |
|
Dec 29, 2021 |
453 |
Accutar Biotechnology Receives FDA Clearance of IND Application for Phase 1 Trial of AC0176 in Prostate Cancer. |
|
|
Dec 27, 2021 |
215 |
Screening and Functional Verification of Selectable Marker Genes for Cordyceps militaris. |
Lou, Haiwei; Zhao, Yu; Zhao, Renyong; Ye, Zhiwei; Lin, Junfang; Guo, Liqiong |
|
Dec 27, 2021 |
5596 |
Taysha added to the ICE biotechnology index. |
|
|
Dec 24, 2021 |
165 |
Taysha added to the ICE biotechnology index. |
|
|
Dec 24, 2021 |
164 |
US blacklists Chinese biotech firms over rights abuses. |
|
|
Dec 24, 2021 |
224 |
Minister stresses use of biotechnology to boost agri production. |
|
|
Dec 24, 2021 |
212 |
The New Era Biotechnology deepens cooperation between China and Belarus. |
|
|
Dec 22, 2021 |
299 |
Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-stage Programs and New Research Collaboration. |
|
|
Dec 22, 2021 |
692 |
India's Bharat Biotech applies to heath regulator for late-stage trial of intranasal COVID-19 vaccine booster. |
|
|
Dec 20, 2021 |
191 |
India's Bharat Biotech applies to heath regulator for late-stage trial of intranasal COVID-19 vaccine booster. |
|
|
Dec 20, 2021 |
192 |
Seychelles receives 40,000 Pfizer-Biotech COVID-19 vaccines from U.S. government. |
|
|
Dec 18, 2021 |
502 |
ARISTA Biotech Confirms Antigen Test Effectiveness Against Omicron and other COVID variants. |
|
|
Dec 15, 2021 |
655 |
SQZ Biotechnologies Data Shows Lead Cell Therapy Candidate Induced Radiographic, Symptomatic and Immune Response as Monotherapy in Post-Checkpoint HPV+ Solid Tumor Patient. |
|
|
Dec 9, 2021 |
539 |
Boston Properties's JV signs full-building lease with biotech firm at 751 Gateway in San Francisco. |
|
|
Dec 7, 2021 |
244 |
ExpreS2ion Biotechnologies ApS reports positive results in COVID-19 booster trial. |
|
Financial report |
Dec 6, 2021 |
171 |
ExpreS2ion Biotechnologies ApS reports positive results in COVID-19 booster trial. |
|
Financial report |
Dec 6, 2021 |
173 |
ExpreS2ion Biotechnologies ApS reports positive results in COVID-19 booster trial. |
|
Financial report |
Dec 6, 2021 |
172 |
MingMed Biotechnology's Investigational New Drug application for PRJ1-3024 receives US FDA approval. |
|
|
Dec 3, 2021 |
211 |
MingMed Biotechnology's Investigational New Drug application for PRJ1-3024 receives US FDA approval. |
|
|
Dec 3, 2021 |
212 |
SQZ Biotechnologies Accepted by Roche Accelerator in China. |
|
|
Dec 2, 2021 |
267 |
Biotech firm has relocated to Deeside. |
|
|
Dec 1, 2021 |
228 |
Premas Biotech and Oravax Medical to initiate testing of oral virus-like particle (VLP) vaccine candidate against Omicron variant of SARS-CoV 2 virus. |
|
|
Dec 1, 2021 |
254 |
Premas Biotech and Oravax Medical to initiate testing of oral virus-like particle (VLP) vaccine candidate against Omicron variant of SARS-CoV 2 virus. |
|
|
Dec 1, 2021 |
255 |
Keeping Chinese Rinding Out of U.S. Biotech. |
Du, Eric |
|
Dec 1, 2021 |
1937 |
In silico Analysis of Virulence, Resistance Genes and Phylogeny of Helicobacter pylori Strains from Different Continents/Farkli Kitalardaki Helicobacter pylori Suslarinin Virulans, Direnc Genleri ve Filogenisinin in silico Analizi. |
Demirci, Mehmet; Unlu, Ozge; Kocazeybek, Bekir S. |
|
Dec 1, 2021 |
5154 |
Pharmaniaga: Sinovac Biotech closely monitoring clinical study progress of Covid-19 Omicron variant. |
|
Clinical report |
Nov 30, 2021 |
258 |
Sartorius Stedim Biotech to expand French facilities capacities for production, innovation, and storage. |
|
|
Nov 29, 2021 |
200 |
Sartorius Stedim Biotech to expand French facilities capacities for production, innovation, and storage. |
|
|
Nov 29, 2021 |
201 |
N1.6bn Budget For NABDA Grossly Inadequate - Prof. Mustapha. |
|
|
Nov 28, 2021 |
1864 |
NBMA To Ensure Equity In Application Of Modern Biotech. |
|
|
Nov 28, 2021 |
428 |
Study suggests Bharat Biotech's COVID-19 vaccine 50% effective at height of India's infections. |
|
|
Nov 24, 2021 |
208 |
Study suggests Bharat Biotech's COVID-19 vaccine 50% effective at height of India's infections. |
|
|
Nov 24, 2021 |
207 |
Food security: AATF scores Nigeria high in biotech deployment, adoption. |
|
|
Nov 23, 2021 |
469 |
Gilead Exercises Options to Three Arcus Biosciences Clinical-stage Programs and Adds Research Collaboration. |
|
|
Nov 22, 2021 |
656 |
ImStem Biotechnology doses first United States multiple sclerosis patient with IMS001. |
|
|
Nov 19, 2021 |
194 |
ImStem Biotechnology doses first United States multiple sclerosis patient with IMS001. |
|
|
Nov 19, 2021 |
195 |
The New Era Biotechnology deepens cooperation between China and Belarus in the CBIP. |
|
|
Nov 19, 2021 |
278 |
Greenleaf Biotech Took Me Out Of Nigeria For The First Time - Zakari. |
|
|
Nov 12, 2021 |
1292 |
Who's Who: Abdulrahman A. Alolayan, CEO of Dammam Biotech Valley. |
Arab News |
|
Nov 8, 2021 |
330 |
Nigeria, Cuba To Deepen Relationship In Biotechnology Development. |
|
|
Nov 8, 2021 |
266 |
Nigeria, Cuba To Strengthen Cooperation On Biotechnology Development. |
|
|
Nov 8, 2021 |
258 |
Puma Biotechnology reports Q3 adjusted EPS (99c), consensus (31c). |
|
Financial report |
Nov 4, 2021 |
162 |
Adverum Biotechnologies reports Q3 EPS (39c), consensus (37c). |
|
Financial report |
Nov 4, 2021 |
179 |
Zimbabwe to vaccinate 16 and 17 year-olds with Sinovac Biotech's COVID-19 vaccine. |
|
|
Nov 2, 2021 |
166 |
Zimbabwe to vaccinate 16 and 17 year-olds with Sinovac Biotech's COVID-19 vaccine. |
|
|
Nov 2, 2021 |
165 |
Nautilus Biotechnology, Abcam partner for exploration of the proteome. |
|
|
Nov 2, 2021 |
156 |
Legend Biotech announces extension of PDUFA date for Cilta-Cel. |
|
|
Nov 1, 2021 |
187 |
Life sciences raised $1 billion in capital last year, and we know why: Covid gave several biotech companies a boost. |
Mumford, Jacqueline |
|
Nov 1, 2021 |
1663 |
Krystal Biotech announces completion of the GEM-3 Phase 3 study evaluating B-VEC. |
|
|
Oct 26, 2021 |
170 |
Evaxion Biotech announces filing of registration statement in the the U.S. |
|
|
Oct 26, 2021 |
173 |
Purple Biotech expands collaboration to evaluate NT219, immuno-oncology drugs. |
|
|
Oct 26, 2021 |
157 |
Matica Biotechnology signs joint research agreement with Sartorius. |
|
|
Oct 19, 2021 |
202 |
Matica Biotechnology signs joint research agreement with Sartorius. |
|
|
Oct 19, 2021 |
201 |
PerkinElmer, Honeycomb Biotechnologies Launch the HIVE scRNAseq Solution for Single-Cell Analysis. |
|
|
Oct 19, 2021 |
364 |
Avidity Biosciences lead program AOC 1001 granted Fast Track Designation by FDA. |
|
|
Oct 18, 2021 |
165 |
Twist Bioscience, the Broad Institute Create Custom Whole Exome Target Enrichment Panel for Clinical Research. |
|
|
Oct 18, 2021 |
334 |
Fortress Biotech, Cyprium Therapeutics announce 'positive' CUTX101 clinical data. |
|
|
Oct 13, 2021 |
187 |
ViA?t Nam to further develop biotechnology industry by 2030. |
|
|
Oct 13, 2021 |
182 |
ViA?t Nam-RoK jointly-founded institute promotes R&D in biotechnology. |
|
|
Oct 8, 2021 |
449 |
Curative Biotechnology licenses IMT504 from Mid-Atlantic BioTherapeutics for development of COVID-19 Vaccine. |
|
|
Oct 8, 2021 |
188 |
Curative Biotechnology licenses IMT504 from Mid-Atlantic BioTherapeutics for development of COVID-19 Vaccine. |
|
|
Oct 8, 2021 |
187 |
Fortress Biotech, Cyprium Therapeutics announce clinical data for CUTX-101. |
|
|
Oct 8, 2021 |
412 |
Brickell Biotech reports 'positive' results from Phase 3 Cardigan I, II studies. |
|
|
Oct 7, 2021 |
284 |
Unity Biotechnology announces 12-week data from Phase 1 trial of UBX1325. |
|
|
Oct 5, 2021 |
402 |
Biotechnology Can Help Achieve SDGs, Food Security- Experts. |
|
|
Oct 4, 2021 |
500 |
Saudi Arabia's TRSDC teams up with Austrian biotech for sustainable food production. |
Arab News |
|
Oct 4, 2021 |
218 |
Public urged: Take part in science-based discussions on biotech products' safety. |
|
|
Oct 3, 2021 |
615 |
The significant influence of residual feed intake on flavor precursors and biomolecules in slow-growing Korat chicken meat. |
Poompramun, Chotima; Molee, Wittawat; Thumanu, Kanjana; Molee, Amonrat |
|
Oct 1, 2021 |
6791 |
Emerging Military Technologies: Background and Issues for Congress. |
Sayler, Kelley M. |
Report |
Oct 1, 2021 |
16889 |
Adaptive Biotechnologies launches closeSEQ assay reports. |
|
|
Sep 30, 2021 |
229 |
Krystal Biotech receives approval from HREC in Australia for Phase 1 KB407 trial. |
|
|
Sep 29, 2021 |
320 |
PharmaCyte Biotech announces encapsulation material does not alter cellular DNA. |
|
|
Sep 27, 2021 |
256 |
US biotech billionaire to make COVID, cancer vaccines in S. Africa. |
|
|
Sep 24, 2021 |
377 |
THE DEATH OF THE GENUS CLAIM. |
Karshtedt, Dmitry; Lemley, Mark A.; Seymore, Sean B. |
|
Sep 22, 2021 |
35229 |
Persephone Biosciences Forges Collaboration with Janssen Biotech. |
|
|
Sep 21, 2021 |
252 |
PDS Biotechnology achieves safety requirement milestone in VERSATILE-002 trial. |
|
|
Sep 20, 2021 |
345 |
Edesa Biotech announces Phase 2 data of EB05 treatment of CVOID-19 patients. |
|
Clinical report |
Sep 20, 2021 |
380 |
Adaptive Biotechnologies to present new COVID-19 data from immune platform. |
|
|
Sep 16, 2021 |
269 |
PharmaCyte Biotech announces first test results of CypCaps clinical trial. |
|
|
Sep 16, 2021 |
168 |
Saudi Arabia set to be 'regional hub' in biotechnology. |
Rashid Hassan |
|
Sep 15, 2021 |
726 |
PDS Biotechnology reports inducement grant under Nasdaq listing rule. |
|
|
Sep 15, 2021 |
169 |
Legend Biotech Begins Phase 1 Clinical Trial in the US to Evaluate Investigational Anti-CD4 CAR-T Therapy for Relapsed or Refractory T-Cell Lymphoma. |
|
|
Sep 13, 2021 |
382 |
Purple Biotech to present overview of ongoing Phase 1b/2 trial of CM24. |
|
|
Sep 13, 2021 |
378 |
Legend Biotech starts U.S. trial to evaluate LB1901, CAR-T, therapy for CTCL. |
|
|
Sep 13, 2021 |
213 |
Boehringer Ingelheim partners with Twist Bioscience for multiple antibody research programmes. |
|
|
Sep 10, 2021 |
183 |
Boehringer Ingelheim partners with Twist Bioscience for multiple antibody research programmes. |
|
|
Sep 10, 2021 |
182 |
Sinovac Biotech announces new research on CoronaVac third dose. |
|
|
Sep 9, 2021 |
196 |
Trinity Biotech reports Q2 adjusted EPS 20.3c vs. 1c last year. |
|
Financial report |
Sep 9, 2021 |
260 |
Riyadh to host global summit on medical biotechnology in September. |
Rashid Hassan |
|
Sep 1, 2021 |
434 |
PharmaCyte Biotech announces CypCaps remains stable, active at 18 months. |
|
|
Aug 31, 2021 |
153 |
Saudi Biotech Center to improve the health of an oil-dependent economy. |
Arab News |
|
Aug 26, 2021 |
694 |
Vertex Pharmaceuticals, Arbr Biotechnologies establish new collaboration. |
|
|
Aug 24, 2021 |
176 |
Vir Biotechnology announces first marketing authorization for sotrovimab. |
|
|
Aug 23, 2021 |
287 |
Alligator Bioscience and Orion Corporation sign research collaboration and license agreement. |
|
|
Aug 19, 2021 |
187 |
Alligator Bioscience and Orion Corporation sign research collaboration and license agreement. |
|
|
Aug 19, 2021 |
188 |
Alligator Bioscience forms immuno-oncology research collaboration with Orion. |
|
|
Aug 18, 2021 |
169 |
Alligator Bioscience forms immuno-oncology research collaboration with Orion. |
|
|
Aug 18, 2021 |
167 |
Alligator Bioscience forms immuno-oncology research collaboration with Orion. |
|
|
Aug 18, 2021 |
168 |
PBS Biotech Raises USD 10m to Provide Scale-Up Manufacturing Solutions for Cell Therapies. |
|
|
Aug 16, 2021 |
354 |
Brickell Biotech announce final patient completed in Phase 3 Cardigan II study. |
|
|
Aug 16, 2021 |
167 |
Fortress Biotech reports Q2 EPS (4c), consensus (12c). |
|
Financial report |
Aug 16, 2021 |
168 |
Biotech firm raises PS7.5m after float. |
|
|
Aug 14, 2021 |
226 |
Globe Biotech hopes for Bangavax human trials September. |
|
|
Aug 13, 2021 |
549 |
PharmaCyte Biotech concludes USD15m public offering. |
|
|
Aug 13, 2021 |
156 |
Evaxion Biotech reports Q2 EPS(36c) , consensus (29c). |
|
Financial report |
Aug 12, 2021 |
200 |
PDS Biotechnology reports Q2 EPS (3c), consensus (17c). |
|
Financial report |
Aug 12, 2021 |
177 |
Portage Biotech issues letter to shareholders. |
|
|
Aug 12, 2021 |
300 |
PharmaCyte Biotech expects USD15m from public offering and uplists to NASDAQ. |
|
|
Aug 11, 2021 |
247 |
PharmaCyte Biotech expects USD15m from public offering and uplists to NASDAQ. |
|
|
Aug 11, 2021 |
248 |
Unity Biotechnology reports Q2 EPS (32c), consensus (31c). |
|
Financial report |
Aug 10, 2021 |
220 |
Portage Biotech doses first patient in IMP-MEL study of PORT-2. |
|
|
Aug 5, 2021 |
200 |
Purple Biotech reports 1H EPS (59c) vs. ($4.63) last year. |
|
Clinical report |
Aug 5, 2021 |
229 |
Adverum Biotechnologies reports Q2 EPS (45c), consensus (38c). |
|
Financial report |
Aug 5, 2021 |
243 |
Vir Biotechnology reports Q2 EPS 46c, consensus (48c). |
|
Financial report |
Aug 5, 2021 |
201 |
Castle Biosciences Collaborates with the Melanoma Research Foundation. |
|
|
Aug 4, 2021 |
589 |
PharmaCyte Biotech to upgrade to the Nasdaq Capital Market and announces upcoming public offering. |
|
|
Aug 3, 2021 |
217 |
PharmaCyte Biotech to upgrade to the Nasdaq Capital Market and announces upcoming public offering. |
|
|
Aug 3, 2021 |
216 |
Dhaka University team wins 1st biotech quiz competition. |
|
|
Aug 2, 2021 |
201 |
Castle Biosciences collaborates with the Melanoma Research Foundation. |
|
|
Aug 2, 2021 |
180 |
SaNOtize Inks Agreement with Indian Biotech Glenmark to Commercialize Nitric Oxide Nasal Spray for COVID-19 Treatment in India and other Asian Markets. |
|
|
Aug 2, 2021 |
476 |
SANOTIZE INKS AGREEMENT WITH INDIAN BIOTECH GLENMARK. |
|
|
Aug 1, 2021 |
544 |
PSU Outperforms PC in Sanitary Biotech Sight Gauge: Manufacturer of single-use systems for biotech applications opts for PSU over PC for improved heat and chemical resistance. |
Sherman, Lilli Manolis |
|
Aug 1, 2021 |
553 |
The Bioeconomy: A Primer. |
Gallo, Marcy E. |
|
Aug 1, 2021 |
13348 |
Portage Biotech reports 2021 EPS ($1.35) vs. (49c) last year. |
|
Financial report |
Jul 28, 2021 |
153 |
Qorvo Biotechnologies Omnia SARS-CoV-2 antigen test platform complete milestone. |
|
|
Jul 28, 2021 |
223 |
Protagonist Therapeutics announces amendment of agreement with Janssen Biotech. |
|
|
Jul 28, 2021 |
312 |
Aurion Biotech trial shows IOTA cell therapy can restore vision to patients with blindness resulting from corneal endothelial disease. |
|
|
Jul 26, 2021 |
286 |
Aurion Biotech Posts Preliminary Findings from IOTA Cell Therapy Trial. |
|
|
Jul 26, 2021 |
415 |
Acticor Biotech Completes Enrollment in its GARDEN Clinical Trial, a COVID-19-induced Acute Respiratory Distress Syndrome Efficacy Study. |
|
Clinical report |
Jul 23, 2021 |
449 |
Unity Biotechnology to host investor call on Phase 1 trial of UBX1325. |
|
|
Jul 23, 2021 |
162 |
Lixte Biotechnology comment on preclinical research on LB-100, dwarfism. |
|
|
Jul 22, 2021 |
243 |
Adverum Biotechnologies no longer plans future development for DME in INFINITY. |
|
|
Jul 22, 2021 |
293 |
NG Biotech unveils COVID-19 antigen self-test Ninonasal for detection of Delta and Epsilon variants across Europe. |
|
|
Jul 19, 2021 |
178 |
NG Biotech unveils COVID-19 antigen self-test Ninonasal for detection of Delta and Epsilon variants across Europe. |
|
|
Jul 19, 2021 |
177 |
GSK To Create Up To 5,000 Jobs As It Plans Huge Biotech Centre. |
|
|
Jul 17, 2021 |
346 |
Trinity Biotech preparing for automated manufacture of TrinScreen HIV. |
|
|
Jul 16, 2021 |
233 |
Trinity Biotech will not devote additional investment to UniGold SARS-CoV-2 test. |
|
|
Jul 16, 2021 |
233 |
Vir Biotechnology initiates Phase 2 clinical trial evaluating VIR-2218, VIR-3434. |
|
|
Jul 15, 2021 |
178 |
AVM Biotechnology receives FDA approval to alter ongoing clinical study. |
|
|
Jul 14, 2021 |
194 |
AVM Biotechnology receives FDA approval to alter ongoing clinical study. |
|
|
Jul 14, 2021 |
195 |
Sana Biotechnology to develop manufacturing facility in Fremont, CA. |
|
|
Jul 14, 2021 |
198 |
Moleculin Biotech receives approval for amendment in Annamycin trial. |
|
|
Jul 13, 2021 |
176 |
Yield10 Bioscience begins 2021 field test, seed scale up program. |
|
|
Jul 13, 2021 |
535 |
Lixte Biotechnology comments on outside research on LB-100's PP2A inhibition. |
|
|
Jul 13, 2021 |
273 |
Atlas Biotechnologies announces launch of Atlas Thrive. |
|
|
Jul 12, 2021 |
167 |
I-Mab signs two new collaborations with Immorna, neoX Biotech. |
|
|
Jul 9, 2021 |
213 |
Evaxion Biotech reports data from Phase 1/2a trials of EVX-01, EVX-02. |
|
|
Jul 8, 2021 |
498 |
NABDA Sensitises FCCPC On Advances In Modern Biotechnology. |
|
|
Jul 8, 2021 |
665 |
Globe Biotech workers assaulted while catching monkeys for vaccine trial. |
|
|
Jul 4, 2021 |
296 |
Acticor Biotech Completes Enrollment in ACTIMIS, its Key Phase 1b/2a Safety Study. |
|
|
Jul 1, 2021 |
468 |
Catalyst Biosciences to host R&D day on CB 4332, complement programs. |
|
|
Jul 1, 2021 |
300 |
Krystal Biotech gives update on trial evaluating topical KB105 for ichthyosis. |
|
|
Jul 1, 2021 |
230 |
Happiness Biotech enters securities purchase agreement for registered direct placement of USD 2.16m to strategic investors. |
|
|
Jun 30, 2021 |
164 |
Happiness Biotech enters securities purchase agreement for registered direct placement of USD 2.16m to strategic investors. |
|
|
Jun 30, 2021 |
162 |
Vir Biotechnology presents clinical data from trials of VIR-2218, VIR-3434. |
|
|
Jun 25, 2021 |
732 |